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Edited by Ulrike KutayAbstract RNAs in cells are associated with RNA-binding pro-
teins (RBPs) to form ribonucleoprotein (RNP) complexes. The
RBPs inﬂuence the structure and interactions of the RNAs and
play critical roles in their biogenesis, stability, function, trans-
port and cellular localization. Eukaryotic cells encode a large
number of RBPs (thousands in vertebrates), each of which has
unique RNA-binding activity and protein–protein interaction
characteristics. The remarkable diversity of RBPs, which
appears to have increased during evolution in parallel to the in-
crease in the number of introns, allows eukaryotic cells to utilize
them in an enormous array of combinations giving rise to a
unique RNP for each RNA. In this short review, we focus on
the RBPs that interact with pre-mRNAs and mRNAs and dis-
cuss their roles in the regulation of post-transcriptional gene
expression.
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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In prokaryotes, transcription and translation are physically
coupled. In eukaryotes, these two processes occur in separate
compartments, the nucleus and the cytoplasm, respectively.
This allows eukaryotes to carry out extensive post-transcrip-
tional processing of pre-mRNA that produces a more diverse
assortment of mRNAs from its genome and provides an addi-
tional layer of gene regulation. The pre-mRNA processing
reactions, including splicing, editing and polyadenylation,
commence as soon as pre-mRNAs emerge from their sites of
transcription and are mediated by RBPs and trans-acting
RNAs, themselves present as RNPs (e.g. snRNPs). Although
all RBPs bind RNA, they do so with diﬀerent RNA-sequence
speciﬁcities and aﬃnities. This activity is mediated by a rela-
tively small number of RNA-binding scaﬀolds whose proper-Abbreviations: RBP, RNA-binding protein; RNP, ribonucleoprotein;
hnRNP, heterogeneous ribonucleoprotein; mRNP, messenger ribonu-
cleoprotein; EJC, exon-junction complex; UTR, untranslated region
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doi:10.1016/j.febslet.2008.03.004ties are further modulated by auxiliary domains. The
auxiliary domains can also mediate the interactions of the
RBP with other proteins and, in many cases, are subject to reg-
ulation by post-translational modiﬁcation. As a result, cells are
able to generate numerous RNPs whose composition and
arrangement of components is unique to each mRNA and
the RNPs are further remodeled during the course of the mat-
uration of the mRNA into its functional form. While our focus
here is on the RBPs that are associated with pre-mRNAs and
mRNAs, we note that many RBPs are associated with other
classes of RNAs (for a recent review see [1]), and all of these
are important for cell physiology (Fig. 1). Many of the features
of RBPs that we discuss, however, are general and also apply
to RBPs that are part of many diﬀerent types of RNPs. In the
following, we discuss select examples that illustrate general
principles of the biochemistry and cell biology of RBPs to
highlight their central role in gene expression.2. RNA-binding proteins (RBPs) are numerous and diverse
The discovery of the heterogeneous nuclear ribonucleopro-
teins (hnRNP) and other pre-mRNA/mRNA-binding pro-
teins led to the identiﬁcation of the ﬁrst amino acid motifs
and functional domains that confer binding to RNA [2].
RBPs contain one or, more often, multiple RNA-binding do-
mains. Some well-characterized RNA-binding domains in-
clude the following: RNA-binding domain (RBD, also
known as RNP domain and RNA recognition motif,
RRM); K-homology (KH) domain (type I and type II);
RGG (Arg-Gly-Gly) box; Sm domain; DEAD/DEAH box;
zinc ﬁnger (ZnF, mostly C-x8-X-x5-X-x3-H); double stranded
RNA-binding domain (dsRBD); cold-shock domain; Pumilio/
FBF (PUF or Pum-HD) domain; and the Piwi/Argonaute/
Zwille (PAZ) domain (Fig. 2) (for review see [3,4]). Using
these motifs, bioinformatic analyses revealed that eukaryotic
genomes encode a large number of RBPs. In yeast, 5–8%
of genes encode proteins predicted to function as RBPs,
and in Caenorhabditis elegans and Drosophila melanogaster,
approximately 2% of the genome is annotated to encode
RBPs [5–7]. However, it is likely that the number of RBPs
is much higher, since there are probably other RNA-binding
domains that remain to be uncovered. Why do eukaryotes
need so many – hundreds and perhaps thousands of – RBPs?
One possible explanation is that as eukaryotes evolved highly
speciﬁc post-transcriptional processes to ﬁne-tune gene
expression, a concomitant expansion of the number of RBPsblished by Elsevier B.V. All rights reserved.
Fig. 1. RNA-binding proteins (RBPs) function in multiple cellular processes. Genetic information stored in chromosomal DNA is translated into
proteins through mRNAs. This allows for post-transcriptional control of gene expression conferring a crucial role to the mRNA-binding proteins in
this regulation. In addition to the RBPs associated with mRNA, many diﬀerent classes of RBPs interact with various small non-coding RNAs to
form ribonucleoprotein (RNP) complexes that are actively involved in many diﬀerent aspects of cell metabolism, such as DNA replication, expression
of histone genes, regulation of transcription and translational control.
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example, in both vertebrates and plants, the emergence of
alternative splicing during evolution drove the need for a cor-
responding increase in the number of RBPs [8].
It is certain that many RBPs remain yet to be characterized.
Several methods have been developed to identify and charac-
terize the RBPs and the RNAs with which they interact. The
hnRNP and messenger RNP (mRNP) complexes were initially
isolated by ultraviolet (UV) cross-linking of RNA–protein
complexes in vivo [9–15]. This is a reliable and eﬀective method
to detect RNA–protein interactions, as it circumvents the
adventitious association of proteins with RNAs that could oc-
cur after cell lysis [16]. Recently, this method has been adapted,
using tagged proteins and including an immunoprecipitation
step following cross-linking (cross-linking and immunoprecip-
itation or CLIP) [17]. Procedures to detect and delineate
RNA–protein interactions in vitro include systematic evolu-
tion of ligands by exponential enrichment (SELEX) and elec-
trophoretic mobility shift assay (EMSA) [18]. A yeast-three
hybrid system has been devised as a screening method to iden-
tify RBPs and their target RNAs [19–21]. Several approaches
have been utilized to identify RNA targets. For example, the
RIP assay, which combines reversible cross-linking with form-aldehyde followed by immunoprecipitation and RT-PCR, has
been used to identify hepatitis delta antigen (HDAg) interac-
tions with HDV RNAs and U1 snRNP protein–RNA interac-
tions [22]. An aﬃnity tag may also be introduced to facilitate
the isolation of an RBP of interest, followed by analysis of
associated RNAs using microarrays, an approach that has
been successfully used to identify RNAs that associate with
PUF proteins in Saccharomyces cerevisiae [23]. Bioinformatics
approaches can also be used to identify RNA targets if a con-
sensus and non-degenerate RNA-binding sequence is known.
In addition, traditional genetic approaches and reverse genet-
ics can be employed to identify both RBPs and their target
RNAs. For example, RNAi screening in cultured D. melano-
gaster cells using a candidate gene approach has been success-
fully used to examine which RBPs are involved in alternative
splicing [24]. Taken together, a considerable array of technol-
ogies is now available to discover and further study the many
RBPs that bioinformatics predicts to be present.
At the structural level, RBPs often exhibit a high degree of
modularity, as most contain one or more RNA-binding and
auxiliary domains (for review see [4]). This modularity creates
both RNA-binding and functional diversity within the RBPs.
The most extensively studied RNA-binding domain, the
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Fig. 2. RNA-binding domains of RBPs. Often, several RNA-binding domains are found within one RBP. Diﬀerent RNA-binding domains include
the RNA-binding domain (RBD), K-homology (KH) domain, RGG (Arg-Gly-Gly) box, double stranded RNA-binding domain (dsRBD), Piwi/
Argonaute/Zwille (PAZ) domain, RNA helicase DEAD/DEAH box, RNA-binding zinc ﬁnger (ZnF) and Puf RNA-binding repeats (Puf). All are
presented as colored boxes.
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exempliﬁed by the polypyrimidine tract-binding protein (PTB/
hnRNP I), poly(A) binding protein (PABP), U2AF65 and
U1A [4]. Although a single RBD, which typically can bind
2–6 nucleotides, is suﬃcient for binding RNA, having multiple
copies of this domain enables the recognition of larger, more
complex RNA targets, enhancing the speciﬁcity and aﬃnity
of binding [25]. A similar principle is found in PUF proteins.
These typically contain eight consecutive Puf RNA-binding re-
peats, each of which consists of approximately 40 amino acids
that form three a-helices [26–28]. The crystal structure of hu-
man Pumilio bound to RNA revealed that each of the eight re-
peats recognizes a single nucleotide in its target RNA, to bind
a total of eight consecutive nucleotides [27]. This speciﬁc and
high aﬃnity interaction, in combination with its modular de-
sign, enables a unique and remarkably predictable PUF-
RNA interaction that can be exploited to engineer proteins
that bind sequences other than wild-type [27,29,30].
A further diversity of RBPs is achieved by combining RNA-
binding domains with auxiliary functional domains. ADAR2
and PKR are two RBPs that have similar RNA-binding do-
mains, the dsRBD, but diﬀer in their auxiliary domains and
their associated functions. ADAR2 combines its dsRBD with
a deaminase domain that converts adenosine to inosine in its
target RNAs, while PKR incorporates a kinase domain
[31,32]. As PKR binds double-stranded RNA, it is converted
to an active state where subsequent autophosphorylation trig-
gers many downstream events [33]. The dsRBD of PKR is thusable to autoregulate its kinase domain due to the modularity of
its structure.
Alternative splicing is yet another mechanism by which cells
can expand their repertoire of RBPs. For example, alternative
splicing of the polypyrimidine tract binding protein (PTB/
hnRNP I) mRNA generates a splice variant that lacks the ﬁrst
two RBDs, and the corresponding PTB isoform may aﬀect the
stability of the CD154 mRNA [34]. Another example of alter-
natively spliced RBPs is the poly(C) binding protein family,
which includes hnRNPs K/J and the aCPs (aCP-1 to -4) (for
review see [35]). HnRNP K appears to have at least four alter-
native splice variants [36]. aCP-2 and aCP-4, two KH domain
RBPs, are both alternatively spliced [35]. However, for these
examples, isoform-speciﬁc functions remain to be determined.
Post-translational modiﬁcation of RBPs generates addi-
tional layers of complexity, as it can modify the RNA-binding,
function and localization of the RNP. Three types of modiﬁca-
tions have been described for RBPs: phosphorylation, arginine
methylation and small ubiquitin-like modiﬁcation (SUMO).
Phosphorylation of aCP-1 and aCP-2 decreases their
poly(rC)-binding activity [37]. Growth factors, oxidative stress
and other stimuli can alter the phosphorylation status of
hnRNP K [38–40]. Methylation of RGG repeats is found in
several RBPs, including the hnRNPs (for review see [41]). In
S. cerevisiae, two RBPs involved in mRNA processing and ex-
port, Hrp1 and Yra1 (Aly/REF in metazoans), have been
shown to be methylated by the major type I arginine methyl-
transferase, Hmt1 [42,43]. It is possible that this methylation
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RNPs. SUMO modiﬁcation of hnRNP C and hnRNP M re-
sults in conformational and/or compositional changes in these
RNPs at the nuclear pore and could therefore play a role in the
regulation of nucleocytoplasmic transport [44].
Cell and developmental speciﬁc expression also serves to al-
ter the stoichiometry of a cells RBPs. Changes in the relative
amounts of hnRNP A/B proteins have been suggested to reg-
ulate alternative splicing, for example that of the 4.1R tran-
script during mouse erythropoiesis [45]. Speciﬁcally, the
hnRNP A/B proteins interact with a conserved splicing silenc-
ing element (CE16) in exon 16 (E16) of the 4.1R transcript,
leading to increased exclusion of E16. In turn, down-regulation
of hnRNP A/B proteins during erythropoiesis correlates with
E16 inclusion. This illustrates the importance of RBPs as mod-
ulators of a process, in this case alternative splicing, in the
broader context of cellular diﬀerentiation.3. Diverse functions of RBPs
RBPs function in every aspect of RNA biology, from tran-
scription, pre-mRNA splicing and polyadenylation to RNA
modiﬁcation, transport, localization, translation and turnover.Fig. 3. The function of RBPs in the regulation of post-transcriptional gene e
the nucleus, they undergo many diﬀerent processing steps that can determine
exon-junction complex (EJC) occurs speciﬁcally on spliced mRNAs, and th
recruitment of ribosomal subunits for translation initiation, or surveillance o
for example, to the 3 0UTR of an mRNA can repress the initiation of tran
mRNAs, upon transport to the cytoplasm, are further modiﬁed by the cytoThe RBPs not only inﬂuence each of these processes, but also
provide a link between them [46–49]. Proper functioning of
these intricate networks is essential for the coordination of
complex post-transcriptional events, and their perturbation
can lead to disease (see Fig. 3).
3.1. Alternative splicing
At least 74% of human genes express multiple mRNAs
through alternative splicing [50]. RBPs also function in the reg-
ulation of this process. For example, the neuronal speciﬁc
Nova proteins, each containing three KH domains, control
the alternative splicing of a subset of pre-messenger RNAs
(e.g. gephyrins 1–2, JNK2, ﬂamingo 1, neogenin) by recogniz-
ing intronic YCAY elements (Y indicates a pyrimidine, U or
C). The majority of Nova target mRNAs encode proteins that
function in the synapse thus linking Nova proteins to the reg-
ulation of factors involved in maintaining neuronal plasticity.
Loss of Nova proteins, as a result of autoimmune paraneoplas-
tic neurologic disorder (PND), manifests itself in neurologic
symptoms of excess motor movements (Paraneoplastic Opso-
clonus Myoclonus Ataxia, POMA) [51,52]. The TAR DNA
binding protein (TDP43), which interacts with (UG)6–12 motifs
in single-stranded RNA through its two RBDs [53], is involved
in the regulation of splicing of the cystic ﬁbrosis CFTR (cysticxpression. Once pre-mRNAs are transcribed by RNA polymerase II in
the fate of the transcript. During splicing, molecular imprinting of the
is event aﬀects the fate of the mRNPs in the following steps, such as
f mRNA for nonsense-mediated mRNA decay (NMD). RBPs bound,
slation and direct the subcellular localization of the mRNAs. Some
plasmic polyadenylation RNP, CPEB.
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encodes a Cl channel [54]. TDP43 binds an extended stretch
of UG repeats in a (UG)U-rich polymorphic region upstream
of the 3 0 splice site in intron 8, which causes exon 9 skipping in
the CFTR mRNA, consequently producing non-functional
chloride channels in patients with cystic ﬁbrosis [53,54]. In
the case of CFTR, the repeats in the transcript aﬀect the func-
tion of the encoded protein. However, there are a number of
diseases associated with repeats where the aberrant RNA
mediates the disease by a gain-of-function mechanism. This
is the case for myotonic dystrophy (DM). DM type I (DM1)
is caused by a CUG triplet-repeat expansion (from 50 to
>1500 repeats) in the 3 0UTR of the DMPK mRNA [55,56].
This mutant mRNA is retained in the nucleus through its
interaction with two splicing regulators, muscleblind-like pro-
tein 1 (MBNL1) and CUG-binding protein 1 (CUG-BP1)
[56,57], causing splicing defects. MBNL1 becomes sequestered
on the mislocalized repeat-containing RNAs which results in
nuclear depletion and loss of function [56]. CUG-BP1 steady
state-levels, on the other hand, are increased in DM1 due to
hyperphosphorylation of the protein [58]. The resulting change
in the ratio of MBNL1 to CUG-BP1 is correlated with aber-
rant splicing of their target pre-mRNAs [59].
3.2. RNA modiﬁcation
RNA editing is the most prevalent type of RNA modiﬁca-
tion, involving the conversion of adenosine (A) to inosine
(I). This post-transcriptional modiﬁcation changes an RNAs
nucleotide content through the deamination of A–I, in a reac-
tion catalyzed by the ADAR proteins [31]. This processing re-
sults in an RNA sequence that is diﬀerent from that encoded
by the genome and extends the diversity of the gene products.
While the majority of RNA editing occurs in non-coding re-
gions, a few genes have been identiﬁed that are subject to edit-
ing in their coding sequences [60]. The pre-mRNA substrate
required by an ADAR enzyme is often an imperfect duplex
RNA formed by base-pairing between the exon that contains
the adenosine to be edited and an intronic non-coding element
[61]. A classic example of A–I editing is the glutamate receptor
GluR-B mRNA, where a glutamine at the editing site is con-
verted to an arginine. This modiﬁcation changes the conduc-
tance properties of the altered channel [61]. Most of the A–I
modiﬁcations described to date are limited to transcripts in
the nervous system encoding ion channels, G-protein coupled
receptors and the glutamate and serotonin receptors [62].
Mutations in the Drosophila ADAR gene result in neuronal
dysfunction, whereas a homozygous Adar null mutation in
mice results in embryonic lethality [63–65]. In humans, a het-
erozygous functional-null mutation in the ADAR1 gene is less
severe and leads to a skin disease, human pigmentary genoder-
matosis [66].
3.3. Polyadenylation
Polyadenylation of an mRNA has a strong eﬀect on its nu-
clear transport, translation eﬃciency and stability, and all of
these, as well as the process of polyadenylation, depend on spe-
ciﬁc RBPs. All eukaryotic mRNAs, with the exception of rep-
lication-dependent histone mRNAs, are processed to receive 3 0
poly(A) tails of 200 nucleotides. Polyadenylation is a tightly
coupled two-step process in which the transcript is ﬁrst cleaved
between the highly conserved AAUAAA sequence upstreamand a degenerate U/GU rich sequence downstream of the
cleavage site, after which the poly(A) polymerase adds the
poly(A) tail to the cleavage product [67]. One of the necessary
protein complexes in the polyadenylation process is CPSF,
which consists of at least four polypeptides and binds the
canonical AAUAAA site, of which CPSF-160 and CPSF-30
appear to be the key RNA-binding subunits [68]. CPSF, to-
gether with the nuclear poly(A) binding protein (PABPN1),
stimulates the activity of the poly(A) polymerase, which is
essentially inactive on its own [69]. For PABN1 to interact
with the poly(A) tail it needs both the RBD and the argi-
nine-rich C-terminal domain [70]. Short GCG expansions in
the coding region of PABPN1 mRNA have been found to
cause oculopharyngeal muscular dystrophy (OPMD) [71].
These triplet-repeats give rise to an expanded polyalanine tract
in the protein that likely causes mutated PABPN1 oligomers to
accumulate as ﬁlament inclusions in the nuclei of skeletal mus-
cle ﬁbers, thus eliciting nuclear toxicity [71]. PABPN1 is post-
translationally modiﬁed by arginine methylation, and it was re-
cently shown that unmethylated PABPN1 oligomerizes more
readily than methylated PABPN1 [72,73]. This suggests that
the methylation state of the protein also inﬂuences the extent
of nuclear aggregation in OPMD.
3.4. mRNA export
Normally, once pre-mRNA processing is complete, the trans-
lation-ready mRNA is exported from the nucleus to the cyto-
plasm. The cell therefore requires a mechanism to ensure that
only fully processed mRNPs are exported. That is, transcrip-
tion, splicing and 3 0 end processing of themRNAsmust be com-
pleted before export can occur. mRNA export is an excellent
example of the dynamic network of rearrangements in which
RBPs participate. It is a three step process involving the gener-
ation of a cargo-carrier complex in the nucleus, followed by
translocation of the complex through the nuclear pore complex,
and ﬁnally, release of the cargo in the cytoplasm with subse-
quent recycling of the carrier. The TAP/NXF1:p15 heterodimer
is a key player in mRNA export. TAP (known as Mex67 in S.
cerevisiae) was ﬁrst shown to bind to the constitutive transport
element (CTE), an element required for export of retroviral
transcripts, and it was later demonstrated that TAP also has a
role in mRNA export [74,75]. Overexpression of TAP in
Xenopus laevis oocytes increases the export of transcripts that
are otherwise ineﬃciently exported suggesting a direct role for
TAP in mRNA export. As both TAP and p15 show low aﬃnity
for RNA, they require adaptor proteins to mediate the interac-
tion [76,77]. The Aly/REF protein which directly interacts with
TAP, recruits TAP to mRNA, although the precise mechanistic
details of mRNA export remain unclear [78,79].
3.5. mRNA localization
mRNA localization is critical for gene expression by allow-
ing spatially regulated protein production. Localization of
transcripts to a speciﬁc region of the cell during development
has been particularly well studied in S. cerevisiae and D. mel-
anogaster. For example, during cell division in S. cerevisiae,
ASH1 mRNA is actively localized to the bud of the daughter
cell by its association with myosin (Myo4) and actin [80]. This
interaction depends on two other proteins, She2 and She3 [81].
She2 binds as a dimer to localization elements located partly in
the coding region and in the 3 0UTR of the ASH1 mRNA [82].
1982 T. Glisovic et al. / FEBS Letters 582 (2008) 1977–1986Binding to RNA increases the aﬃnity of She2 for the C-termi-
nus of She3, which then binds Myo4 through its N-terminus
[81]. The resultant localized expression of the Ash1 protein is
necessary for the suppression of mating type switching in the
daughter cell by repressing the transcription of the HO endo-
nuclease gene [80]. Another example that highlights how nucle-
ar-acquired factors impact cytoplasmic mRNA metabolism is
the localization of b-actin to the lamella region in several
asymmetric cell types by the zipcode-binding protein (ZBP1)
[83,84]. ZBP1 contains four KH domains and one RBD. It
binds to b-actin mRNA at the site of transcription through a
54 nt localization element in the 3 0UTR of b-actin, termed
the zipcode, and moves with the mRNA into the cytoplasm.
This interaction is essential for proper b-actin mRNA localiza-
tion in the cytoplasm [83,84].
3.6. Translation
Translational regulation provides a rapid mechanism to con-
trol gene expression, and numerous regulatory proteins target
the initiation step, often in a way that couples translation to
mRNA localization. ZBP1, in addition to its role in the local-
ization of b-actin mRNA, is involved in the translational
repression of b-actin mRNA by blocking translation initiation
[85]. It is thought that phosphorylation of ZBP1 by the Src
tyrosine kinase leads to decreased binding aﬃnity to b-actin
mRNA, and ultimately derepression of translation [85]. The
dual role of ZBP1 makes it a valid candidate in linking trans-
port and translational repression of b-actin mRNA.
Many species depend on distinct regulatory systems to keep
mRNAs translationally silent during diﬀerent stages of devel-
opment. In the C. elegans germ line, for example, the KH do-
main protein GLD-1 represses the translation of pal-1 mRNA
by binding to a germline repression element (GRE) in its
3 0UTR [86]. The PAL-1 protein initiates a transcription regu-
latory network in the later blastomere lineages, and therefore
needs to be translationally repressed in oocytes and early em-
bryos [87].
3.7. mRNA turnover
Translation is tightly coupled to mRNA turnover and regu-
lated mRNA stability. The ELAV/Hu proteins are involved
in the stability and translation of early response gene and
AU-rich transcripts predominantly in neurons [88]. HuB,
HuC and HuD are neuron-speciﬁc ELAV proteins, whereas
HuR is ubiquitously expressed [89]. Each contains three RBDs,
the ﬁrst two of which confer binding to AU-rich elements
(AREs) [90]. These proteins stabilize many of their AU-rich tar-
get mRNAs (e.g. c-fos, GM-CSF and EGF) [88]. HuR appears
to be stabilizing its target transcripts by protecting the messages
from degradation in the cytoplasm [91]. In addition, HuR colo-
calizes with polysomes, suggesting that it binds to ARE-con-
taining mRNAs undergoing translation [92]. Patients with
paraneoplastic neurological disorder (PND) develop autoanti-
bodies against HuC and HuD in tumors outside of the central
nervous system [51,52]. These antibodies, as well as inﬂamma-
tory cells, are able to cross the blood-brain barrier resulting in
PND-associated encephalomyelitis and neuronopathy [88].
3.8. Multi-functional proteins
Many RBPs, for example the abundant hnRNP and serine/
arginine-rich (SR) proteins, bind to multiple sites on numerousRNAs to function in diverse processes. The hnRNP A1 protein
can bind to exonic splicing silencer sequences and regulate
alternative splicing by antagonizing the SR splicing factors
[45]. Additionally, hnRNP A1 has been shown to stimulate tel-
omerase activity by associating with telomere ends [93]. Re-
cently, hnRNP A1 was found to bind to human pri-mir18a,
the precursor of miR-18a, and to facilitate its Drosha-medi-
ated processing [94]. This is the ﬁrst time an RBP has been
implicated in miRNA maturation.4. Assembly of RNPs
RNA–protein, and hence the sequence or structure of the
RNA target, and protein–protein interactions are critical fac-
tors in determining the formation of an RNP. However, often
more than one RBP has the capacity to bind to a speciﬁc se-
quence on the target RNA. The complement of RBPs present
at a particular locale where the RNA is transcribed or changes
in the post-translational modiﬁcations of these proteins would
aﬀect the resulting RNP complex, modulating its downstream
functional activity. The recruitment of additional proteins to
the RNP can result in the regulated formation of a highly dy-
namic complex. Here, we discuss two well-characterized exam-
ples of RNP assembly, the exon-junction complex (EJC) and
the CPE-binding protein (CPEB) RNP.
The EJC is a large (335 kDa in vitro) RNP that preferen-
tially binds mRNAs produced by splicing [95–97]. It binds
these newly spliced mRNAs approximately 20–24 nucleotides
upstream of exon–exon junctions [96,97]. Proteins known to
comprise the core EJC include eIF4AIII, Y14, magoh and
MLN51/Barentsz [98–100]. Other proteins that associate with
the core complex include RNPS1, SRm160, Aly/REF, PYM
and Upf3 [95,97,100–107]. Of the core components, the best
characterized interaction occurs between Y14 and magoh,
two proteins that are found in spliceosomes following the ﬁrst
step of splicing [108,109]. While Y14, which contains an RBD,
was initially a candidate for binding mRNA directly, the crys-
tal structure of human and Drosophila Y14:magoh revealed
quite unexpectedly that the RBD is masked through its inter-
action with magoh and, thus, appears unable to directly con-
tact mRNA [95,110–112]. Rather, it is more likely that
eIF4AIII, a spliceosome-associated ATP-dependent DEAD-
box RNA helicase, acts as the central factor in the initiation
of EJC formation because it binds speciﬁcally to mRNA dur-
ing the late stages of splicing and also binds Y14:magoh, per-
haps serving to recruit these proteins to the exon–exon
junction [98–100,107,113]. The EJC also enhances the associa-
tion with the mRNP of the mRNA nuclear export factor TAP/
NXF1:p15, and this promotes its transport of the complex
through the nuclear pore to the cytoplasm
[78,105,106,114,115]. Interestingly, while most EJC proteins
dissociate from the mRNA either during or immediately fol-
lowing export, Y14 and magoh remain bound to the mRNA
until it is translated, suggesting that they may play an addi-
tional role in this process [116]. Consistent with this idea, teth-
ering of Y14, magoh or RNPS1 to mRNA can enhance the
translation eﬃciency [117]. Recently, PYM has been shown
to bind the cytoplasmic Y14:magoh complex, in addition to
the 48S preinitiation complex and the small (40S) ribosomal
subunit [118]. In addition, knockdown of PYM results in a de-
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gests that PYM may deliver spliced mRNAs containing the
EJC to the translational apparatus in the cytoplasm to enhance
protein production. The EJC can also serve as a marker to
indicate mRNAs that have premature stop codons located up-
stream of the EJC (for review see [119]). Upf3, a protein that
functions in nonsense-mediated decay (NMD), is also a com-
ponent of the EJC [105,120]. It appears that information en-
coded by mRNAs, such as the presence or absence of
premature termination codons, may be marked in the nucleus
for subsequent communication to the translation or NMD
apparatus in the cytoplasm. The dynamic nature of the associ-
ation of proteins with mRNA in the EJC RNP over a history
of processes – from splicing to export, translation and mRNA
degradation – implies that this highly ordered RNP assembly is
important for timely and coordinated gene expression.
The CPE-binding protein (CPEB) RNP is a large, dynamic
complex that functions in cytoplasmic polyadenylation and
translational regulation (for review see [121]). CPEB itself con-
tains two RNA-binding domains, an RBD and a zinc ﬁnger,
and is highly conserved in both vertebrates and invertebrates
[122,123]. In the cytoplasm, CPEB ﬁrst binds to the cytoplasmic
polyadenylation element (CPE; UUUUUAU consensus se-
quence), located within the 3 0UTR of some mRNAs, and then
initiates the assembly of an RNP complex that contains the fol-
lowing proteins: CPSF; PARN, a deadenylating enzyme that
contains two RBDs; Gld2, a poly(A) polymerase; and symple-
kin [124–128]. When the CPE-containing mRNA is translation-
ally repressed, PARN deadenylation is more active than Gld2
polyadenylation, resulting in shortening of the poly(A) tail
[129]. However, in the case of oocyte maturation, phosphoryla-
tion of CPEB Ser174 by Aurora A kinase results in the dissoci-
ation of PARN from the RNP complex, allowing Gld2
polyadenylation of the CPE-containing mRNA [128,129].
The maskin protein appears to provide a direct link to transla-
tion regulation and the CPEBRNP.Maskin interacts with both
CPEB and the cap-binding factor eIF4E [130,131]. When the
poly(A) tail is short, maskin binds eIF4E, therefore occluding
the binding of eIF4G. As a result, the 40S ribosomal subunit
cannot be recruited to the mRNA and translation is repressed.
However, when the poly(A) tail is elongated, the poly(A)-bind-
ing protein (PABP) binds the poly(A) tail and interacts directly
with eIF4G to abrogate maskins interaction with eIF4E,
allowing the mRNA to be translated [130,132]. Subtle changes
in the protein composition and mRNA polyadenylation status
of this cytoplasmic RNP complex can determine the fate of the
mRNA to which it is bound. These changes ultimately dictate
whether the poly(A) tail in the CPE-containing mRNA is dead-
enylated and therefore translationally repressed, or is elongated
and consequently subject to translation initiation. The reper-
toire of RBPs that binds a particular RNA is often highly inﬂu-
ential in determining which RNPs form and, ultimately, the
functional roles they play.5. Perspectives
Since the deﬁnitive identiﬁcation of the hnRNP proteins and
the discovery of the ﬁrst consensus motifs in RBPs more than
two decades ago, the list of RBPs and the multitude of func-
tions in which they participate has expanded enormously. Inrecent years, biochemical and genetic experiments as well as
bioinformatic analysis of several sequenced genomes revealed
a vast array of RBPs about which little is known. It is very
likely that the inventory of RBPs is much larger, as it is doubt-
ful that all of the RNA-binding motifs have already been dis-
covered. From what has been learned so far, it is clear that
RBPs are critical components of the gene expression pathway
in eukaryotes. Their capacity to regulate every aspect of the
biogenesis and function of RNAs is remarkable. It is also clear,
however, that a great deal of information is lacking about the
structure of RBPs, their mode of interaction with RNAs and
the speciﬁc arrangements of these proteins in the complex
RNP assemblies that they form on pre-mRNAs and mRNAs.
Given the impressive progress that has already been made, the
enormous number of RBPs that remain to be characterized
and the rich arsenal of tools available to study them, the prom-
ise of what the study of RBPs still has in store for understand-
ing biology and many diseases is tremendously exciting.
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